EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rationale and design of the CORDIAL first-in-human clinical trial: A system for sorbent-assisted continuous flow peritoneal dialysis

Joost Christiaan de Vries iD, Maaike K van Gelder, Dian P Bolhuis, Frank Simonis, Marianne C Verhaar, María Auxiliadora Bajo Rubio, Gloria Del Peso, Rafael Selgas, Gabriele Donati, Giulia Ligabue, Gianni Cappelli, Karin Gf Gerritsen

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · 2026-09 · 46 (5) · 528-534

DOI: 10.1177/08968608251381933 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, online erschienen am 26.09.2025. Verfasst von Joost Christiaan de Vries und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Kidney Failure, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme, Nierstichting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peritoneal dialysis (PD) has important disadvantages compared to hemodialysis, including low plasma clearance and limited technique survival. A new device for sorbent-assisted (continuous flow) peritoneal dialysis (SAPD) has been designed that is based on continuous recirculation of peritoneal dialysate via a single-lumen peritoneal catheter with regeneration of spent dialysate by sorbents. SAPD treatment may enhance plasma clearance of uremic solutes by increasing the mass transfer area coefficient and maintenance of a high plasma-to-dialysate concentration gradient. In addition, SAPD treatment may preserve integrity of the peritoneal membrane for a longer period of time by avoiding the need for high initial glucose concentrations and by reducing the number of exchanges and (dis)connections of the peritoneal catheter, which may lower the risk of peritonitis. The primary aim of this first-in-human clinical trial is to evaluate the (short-term) clinical safety and performance of SAPD treatment in a small group ( n = 12) of stable adult PD patients in a clinical setting (proof of concept). Key secondary objectives include an evaluation of efficacy in terms of plasma clearance, ultrafiltration, and patient tolerance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal DialysisKidney Failure, ChronicHumansEquipment DesignDialysis SolutionsAdultFemaleMale

Stichwörter der Autor:innen

continuous flow peritoneal dialysisfirst-in-human trialsorbent-assisted peritoneal dialysis

Substanzen

Dialysis Solutions

Autor:innen und Institutionen

  • Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Nanodialysis B.V., Oirschot, The Netherlands.
  • Nephrology Service, Hospital Universitario de la Princesa, Health Research Institute (IIS-IP), RICORS, Madrid, Spain.
  • Nephrology Service, Hospital Universitario La Paz, Institute for Health Research (IdiPAZ), RICORDS, Madrid, Spain.
  • Surgical, Medical, Dental, Morphology Sciences, Transplant, Oncology and Regenerative Medicine Department, Division of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.

ORCID-Profile: Joost Christiaan de Vries

Förderung

  • Horizon 2020 Framework Programme
  • Nierstichting

Zitieren

APA

de Vries, J. C., van Gelder, M. K., Bolhuis, D. P., Simonis, F., Verhaar, M. C., Bajo Rubio, M. A., Del Peso, G., Selgas, R., Donati, G., Ligabue, G., Cappelli, G., & Gerritsen, K. G. (2026). Rationale and design of the CORDIAL first-in-human clinical trial: A system for sorbent-assisted continuous flow peritoneal dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 46(5), 528-534. https://doi.org/10.1177/08968608251381933

Vancouver

de Vries JC, van Gelder MK, Bolhuis DP, Simonis F, Verhaar MC, Bajo Rubio MA, et al. Rationale and design of the CORDIAL first-in-human clinical trial: A system for sorbent-assisted continuous flow peritoneal dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2026;46(5):528-534. doi:10.1177/08968608251381933

BibTeX
@article{deVries2026,
  author = {de Vries, Joost Christiaan and van Gelder, Maaike K and Bolhuis, Dian P and Simonis, Frank and Verhaar, Marianne C and Bajo Rubio, María Auxiliadora and Del Peso, Gloria and Selgas, Rafael and Donati, Gabriele and Ligabue, Giulia and Cappelli, Gianni and Gerritsen, Karin Gf},
  title = {Rationale and design of the CORDIAL first-in-human clinical trial: A system for sorbent-assisted continuous flow peritoneal dialysis},
  journal = {Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis},
  year = {2026},
  volume = {46},
  number = {5},
  pages = {528--534},
  doi = {10.1177/08968608251381933}
}
Kostenlos starten →